Having trouble reading this email? View the web version here \| Forward this email to a colleague

Sanofi appoints David Meeker as Genzyme’s new Chief Executive Officer

Sanofi has announced the appointment of David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November 1, 2011.

David will report to Christopher A. Viehbacher, Chief Executive Officer of Sanofi, and will join the Group Management Committee...

Read more >>

More pharmaceutical & life science news:

		Gilead and GlobeImmune announce license and collaboration agreement to develop therapeutic vaccine products Gilead & GlobeImmune enter into an exclusive worldwide license & collaboration agreement...

		Abbott’s genetic test for acute myeloid leukemia prognosis cleared by FDA New test based on FISH technology detects chromosomal abnormality to help predict prognosis of patients with AML...

		Novartis Phase II data show AIN457 provided rapid and significant relief of symptoms in up to 81% of patients with psoriasis Positive results from three Phase II trials...

		Merck announces presentation of Phase III investigational studies evaluating DULERA® (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol in COPD Merck announced results from two 26-week investigational Phase III clinical studies...

		Biogen Idec and Abbott present positive data for Daclizumab HYP from Select Phase 2b trial at ECTRIMS/ACTRIMS Biogen Idec and Abbott announced additional results from the SELECT Phase 2b trial...

		Alemtuzumab significantly reduces relapses in multiple sclerosis vs interferon beta-1a in a Phase III study New results from the CARE-MS I trial...

		Janssen data focus on tolerability and treatment simplification in HIV compounds New HIV data to be presented at EACS 2011...

		Oral BG-12 (Dimethyl Fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression Phase 3 clinical trial demonstrated significant clinical effects...

		ICON selected by the Biomarkers Consortium of the FNIH ICON has announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH)...

		STELARA® (Ustekinumab) is effective, well-tolerated and improves quality of life in patients with moderate to severe plaque psoriasis inadequately responsive to methotrexate New data presented at EADV...

		AstraZeneca to present new healthcare economics data demonstrating cost-effectiveness of BRILIQUE AstraZeneca will present key results from health economics sub-studies...

Events, conferences & exhibitions:

European Pharmaceutical Pricing & Reimbursement
31 October - 1 November 2011, Basel, Switzerland

BIT’s 1st Annual Symposium of Drug Delivery Systems 2011
3 - 5 November 2011 Liaoning, China

BIT’s 9th Annual Congress of International Drug Discovery Science and Technology
3 - 6 November 2011, Shenzden, China

BIT’s 2nd Annual World Congress of NanoMedicine 2011
3 - 6 November 2011, Guangdong, China

Lyophilization Technology – Practical Application of the Scientific Principles
7 - 9 November 2011, Berlin, Germany

Mass Spec Europe
8 - 9 November 2011, Dublin, Ireland

Preparation, Labelling and Packaging of Clinical Trial Supplies
21 - 23 November 2011, London, UK

10th Annual World Drug Manufacturing Summit
29 November - 1 December 2011, Berlin, Germany

IFPAC 2012
22 - 25 January 2012 Baltimore, USA

The New Health is data driven. Biopharma is swimming in oceans of data, and it’s still growing exponentially. Quintiles is introducing a singular way to aggregate, harmonize and gain insights from your data. Quintiles Infosario™ is a new platform that allows you to view data from multiple sources—sites, labs, ECG, finance, HR and more—all in one place. So you can make better decisions, faster.

Learn how Quintiles can help you move from information to insights—and from insights to outcomes. Watch From Information to Insight at quintiles.com/newhealth

Company directory

Our new look directory includes hundreds of organisations, plus the following Premium listings:

- ABB Analytical Measurements
- Almac
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- CI Precision
- Cisbio Bioassays
- Colder Products Company
- DCA Design International
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Watson-Marlow Pumps Group

Add your company >>

Join European Pharmaceutical Review on LinkedIn

Follow European Pharmaceutical Review on Twitter

Like European Pharmaceutical Review on Facebook